Early versus Late Pre-emptive Allogeneic Hematopoietic Cell Transplantation (p-alloHCT) for Relapsed or Refractory Acute Myeloid Leukemia (AML)

Many patients with relapsed or refractory acute myeloid leukemia (AML) do not receive allogeneic hematopoietic cell transplant (alloHCT) because they are unable to achieve a complete remission (CR) after reinduction chemotherapy. Starting in January 2003, we prospectively assigned patients with AML...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Chen, George L., Liu, Hong, Zhang, Yali, Thomas, Julie, Ross, Maureen, Wang, Eunice S., Block, AnneMarie W., Sait, Sheila, Deeb, George, Wallace, Paul, Wetzler, Meir, Hahn, Theresa, McCarthy, Philip L.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4292802/
https://ncbi.nlm.nih.gov/pubmed/24867777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.05.013
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars